Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464861013 | Bevacizumab 25mg/mL injection solution 16mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 2471196011 | Bevacizumab 25mg/mL injection solution 16mL vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 2477419015 | Bevacizumab 400mg/16mL injection solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 2477420014 | Bevacizumab 400mg injection | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2553470018 | Bevacizumab 400mg/16mL concentrate for solution for infusion | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 46851801000001110 | Bevacizumab 400mg/16ml solution for injection vials | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 53222501000001114 | Bevacizumab 400mg/16ml solution for infusion vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Avastin 400mg/16ml solution for injection vials (Roche Products Ltd) | Is a | False | Bevacizumab 25mg/mL injection solution 16mL vial | Inferred relationship | Existential restriction modifier | |
| Bevacizumab 400mg/16ml solution for injection vials 1 vial | Is pack of | False | Bevacizumab 25mg/mL injection solution 16mL vial | Inferred relationship | Existential restriction modifier | |
| Bevacizumab 400mg/16ml solution for injection vials 1 vial | Has VMP | False | Bevacizumab 25mg/mL injection solution 16mL vial | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets